Merck & Co. (MRK)
(Delayed Data from NYSE)
$130.72 USD
+3.72 (2.93%)
Updated Apr 25, 2024 04:02 PM ET
After-Market: $131.00 +0.28 (0.21%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *BMO4/25/24 |
---|---|
Current Quarter | 1.94 |
EPS Last Quarter | 0.03 |
Last EPS Surprise | 133.33% |
ABR | 1.26 |
Earnings ESP
|
-2.21% |
---|---|
Current Year | 8.57 |
Next Year | 9.89 |
EPS (TTM) | 1.50 |
P/E (F1) | 14.82 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 15.32B | 15.94B | 63.95B | 68.71B |
# of Estimates | 7 | 7 | 7 | 7 |
High Estimate | 15.68B | 16.21B | 64.82B | 71.03B |
Low Estimate | 15.01B | 15.76B | 63.08B | 66.60B |
Year ago Sales | 14.49B | 15.04B | 60.11B | 63.95B |
Year over Year Growth Est. | 5.77% | 6.03% | 6.38% | 7.44% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.94 | 2.16 | 8.57 | 9.89 |
# of Estimates | 8 | 7 | 11 | 9 |
Most Recent Consensus | 1.80 | 2.11 | 8.58 | 9.57 |
High Estimate | 2.07 | 2.27 | 8.78 | 10.50 |
Low Estimate | 1.80 | 1.96 | 8.44 | 9.57 |
Year ago EPS | 1.40 | -2.06 | 1.51 | 8.57 |
Year over Year Growth Est. | 38.57% | 204.85% | 467.55% | 15.41% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 2 | 1 | 2 |
Up Last 30 Days | 0 | 6 | 4 | 5 |
Up Last 60 Days | 0 | 6 | 5 | 6 |
Down Last 7 Days | 2 | 0 | 1 | 0 |
Down Last 30 Days | 6 | 0 | 4 | 1 |
Down Last 60 Days | 6 | 0 | 4 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.94 | 2.16 | 8.57 | 9.89 |
7 Days Ago | 2.01 | 2.09 | 8.57 | 9.83 |
30 Days Ago | 2.12 | 1.96 | 8.58 | 9.83 |
60 Days Ago | 2.13 | 1.96 | 8.53 | 9.71 |
90 Days Ago | 1.99 | 1.98 | 8.47 | 9.49 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.89 | 2.19 | 8.60 | 9.97 |
Zacks Consensus Estimate | 1.94 | 2.16 | 8.57 | 9.89 |
Earnings ESP | -2.21% | 1.51% | 0.38% | 0.79% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.03 | 2.13 | -2.06 | 1.40 | NA |
Estimate | -0.09 | 1.94 | -2.17 | 1.34 | NA |
Difference | 0.12 | 0.19 | 0.11 | 0.06 | 0.12 |
Surprise | 133.33% | 9.79% | 5.07% | 4.48% | 38.17% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more